IL-1β enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC):: A mechanism for T cell-independent DC activation

被引:94
作者
Luft, T
Jefford, M
Luetjens, P
Hochrein, H
Masterman, KA
Maliszewski, C
Shortman, K
Cebon, J
Maraskovsky, E
机构
[1] Austin & Repatriat Med Ctr, Melbourne Tumour Biol Branch, Ludwig Inst Canc Res, Heidelberg, Vic 3084, Australia
[2] Heidelberg Univ, Heidelberg, Germany
[3] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
[4] Immunex Corp, Seattle, WA 98101 USA
关键词
D O I
10.4049/jimmunol.168.2.713
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD40 ligand (CD40L) is a membrane-bound molecule expressed by activated T cells. CD40L potently induces dendritic cell (DC) maturation and IL-12p70 secretion and plays a critical role during T cell priming in the lymph nodes. IFN-gamma and IL-4 are required for CD40L-mediated cytokine secretion, suggesting that T cells are required for optimal CD40L activity. Because CD40L is rapidly up-regulated by non-T cells during inflammation, CD40 stimulation may also be important at the primary infection site. However, a role for T cells at the earliest stages of infection is unclear. The present study demonstrates that the innate immune cell-derived cytokine, 11,4 0, can increase CD40L-induced cytokine secretion by monocyte-derived DC, CD34(+)-derived DC, and peripheral blood DC independently of T cell-derived cytokines. Furthermore, IL-1beta is constitutively produced by monocyte-derived DC and monocytes, and is increased in response to intact Escherichia cola or CD40L, whereas neither CD34(+)-derived DC nor peripheral blood DC produce IL-1beta. Finally, DC activated with CD40L and IL-1beta induce higher levels of IFN-gamma secretion by T cells compared with DC activated with CD40L alone. Therefore, IL-1beta is the first non-T cell-derived cytokine identified that enhances CD40L-mediated activation of DC: The synergy between CD40L and IL-1beta highlights a potent, T cell-independent mechanism for DC activation during the earliest stages of inflammatory responses.
引用
收藏
页码:713 / 722
页数:10
相关论文
共 58 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[3]   Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor β1 and β2 chain expression [J].
Braun, MC ;
He, JP ;
Wu, CY ;
Kelsall, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (03) :541-552
[4]  
CASTRO AG, 1995, J IMMUNOL, V155, P2013
[5]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[6]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752
[7]   Maturation, activation, and protection of dendritic cells induced by double-stranded RNA [J].
Cella, M ;
Salio, M ;
Sakakibara, Y ;
Langen, H ;
Julkunen, I ;
Lanzavecchia, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :821-829
[8]  
de Saint-Vis B, 1998, J IMMUNOL, V160, P1666
[9]   Interleukin-12 and tumor necrosis factor alpha mediate innate production of gamma interferon by group B streptococcus-treated splenocytes of severe combined immunodeficiency mice [J].
Derrico, CA ;
Goodrum, KJ .
INFECTION AND IMMUNITY, 1996, 64 (04) :1314-1320
[10]   Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4 [J].
Ebner, S ;
Ratzinger, G ;
Krösbacher, B ;
Schmuth, M ;
Weiss, A ;
Reider, D ;
Kroczek, RA ;
Herold, M ;
Heufler, C ;
Fritsch, P ;
Romani, N .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :633-641